Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 25 or more amino acid residues in defined sequence
Reexamination Certificate
2006-04-25
2006-04-25
Wessendorf, T. D. (Department: 1639)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
25 or more amino acid residues in defined sequence
C530S350000, C530S300000, C424S228100, C424S227100, C424S226100, C424S204100
Reexamination Certificate
active
07034108
ABSTRACT:
Peptides which are mimotopes of the hypervariable region 1 (HVR1) of the putative envelope protein E2 of hepatitis C virus (HCV) are provided, useful in obtaining antibodies and raising an immune response cross-reactive against different strains of HCV.
REFERENCES:
patent: 5643768 (1997-07-01), Kawasaki
patent: 5658754 (1997-08-01), Kawasaki
patent: WO 92/01047 (1992-01-01), None
patent: WO 94/26306 (1994-11-01), None
patent: WO 94/26886 (1994-11-01), None
patent: WO 95/11922 (1995-05-01), None
patent: WO 95/14110 (1995-05-01), None
Cormack, B. et al. “Regional Codon Randomization: Defining a TATA-Binding Protein Surface Required for RNA Polymerase III Transcription”, Science, 1993, vol. 262, pp. 244-248.
Cortese, R. et al. “Epitope discovery using peptide libraries displayed on phage”, Trends Biotechnol, 1994, vol., 12, pp. 262-267.
Cortese, R. et al. “Selection of biologically active peptides by phage display of random peptide libraries”, Current Opinion in Biotechnology, 1996, vol. 7, pp. 616-621.
Farci, P. et al. “Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization”, Proc Natl Acad Sci USA, 1994, vol. 91, pp. 7792-7796.
Farci, P. et al. “Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serume against the hypervariable region 1 of the envelope 2 protein”, Proc Natl Acad Sci USA, 1996, vol. 93, pp. 15394-15399.
Folgori, A. et al. “A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera”, The EMBO Journal, 1994, vol. 13, pp. 2236-2243.
Major, M. et al. “DNA-Based Immunization with Chimeric Vectors for the Induction of Immune Responses against the Hepatitis C Virus Nucleocapsid”, Journal of Virology, 1995, vol. 69, pp. 5798-5805.
Mecchia, M. et al. “Nonrheumatoid IgM in Human Hepatitis C Virus-Associated Type II Cryoglobulinemia Recognize Mimotopes of the CD4-Like LAG-3 Protein”, The Jouranl of Immunology, 1996, vol. 157, pp. 3727-3736.
Meola, A. et al. “Derivation of Vaccines From Mimotopes. Immunologic Properties of Human Hepatitis B Virus Surface Antigen Mimotopes Displayed on Filamentous Phage”, The Journal of Immunology, 1995, vol. 154, pp. 3162-3172.
Pessi, A. et al. “Application of the Continuous-flow Polyamide Method to the Solid-phase Synthesis of a Multiple Antigen Peptide (MAP) based on the Sequence of a Malaria Epitope”, J of Chem Soc, Chemical Communications, 1990, vol. 1, pp. 8-9.
Prezzi, C. et al. “Selection of Antigenic and Immunogenic Mimics of Hepatitis C Virus Using Sera from Patients”, The Journal of Immunology, 1996, vol. 156, pp. 4504-4513.
Scarselli, E. et la. “Occurrence of Antibodies Reactive with More than One Variant of the Putative Envelope Glycoprotein (gp70) Hypervariable Region 1 in Viremic Hepatitis C Virus-Infected Patients”, Journal of Virology, 1995, vol. 69, pp. 4407-4412.
Shimizu, Y. et al. “Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line”, Pro Natl Acad Sci USA, 1992, vol. 89, pp. 5477-5481.
Simmonds, P. et al. “Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region”, Journal of General Virology, 1993, vol. 74, pp. 2391-2399.
Tam, J. “Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system”, Proc Natl Acad Sci USA, 1988, vol. 85, pp. 5409-5413.
Weiner, A. et al. “Variable and Hypervariable Domains Are Found in the Regions of HCV Corresponding to the Flavivirus Envelope and NS1 Proteins and the Pestivirus Envelope Glycoproteins”, Virology, 1991, vol. 180, pp. 842-848.
Winter G. et al. “Man-made antibodies”, Nature, 1991, vol. 349, pp. 293-299.
Kato, N. et al. “Characterization of Hypervariable Regions in the Putative Envelope Protein of Hepatits C Virus”, Biochem and Biophys Res Commun, 1992, vol. 189, pp. 119-127.
Takeuchi, K. et al. “Hepatitis C viral cDNA clones isolated from a healthy carrier donor implicated in post-transfusion non-A, non-B hepatitis”, Gene, 1990, vol. 91, pp. 287-291.
Hohne, M. et al. “Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak”, Arch Virol, 1994, vol. 137, pp. 25-34.
Wang, Y. et al. “Prevalence, Genotypes, and an Isolate (HC-C2) of Hepatitis C Virus in Chinese Patients With Liver Disease”, Journal of Medical Virology, 1993, vol. 40, pp. 254-260.
Okamoto, H. et al. “Molecular and clinical characteristics of the hepatitis C virus genotype “2c” found in Italians in Italy and France”, International Hepatology Communications, 1995, vol. 3, pp. 161-165.
Kato, N. et al. “Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis”, Proc Natl Acad Sci USA, 1990, vol. 87, pp. 9524-9528.
Okamoto, H. et al. “The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Idonesian patient with chronic liver disease”, Journal of General Virology, 1994, vol. 75, pp. 629-635.
Kato, N. et al. “Marked sequence diversity in the putative envelope proteins of hepatitis C viruses ”, Virus Research, 1992, vol. 22, pp. 107-123.
Sarashina, T. et al. “Nucleotide sequence of the hepatitis C virus genome from a patient negative for anti-HCV by the first generation antibody assay”, Nucleic Acids Research, 1993, vol. 21, pp. 1037.
Tokita, H. et al. “Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups”, Proc Natl Acad Sci USA, 1994, vol. 91, pp. 11022-11026.
Abe, K. et al. “Genomic characterization and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic of non-A, non-B hepatitis in Japan”, Journal of General Virology, 1992, vol. 73, pp. 2725-2729.
Okamoto, H. et al. “Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specifics detection”, Journal of General Virology, 1993, vol. 74, pp. 2385-2390.
Seki, M. et al. “Effective production of hepatitis C virus core antigen having high purity inEscherichia coli”, Journal of Biotechnology, 1995, vol. 38, pp. 229-241.
Kato, N. et al. Accession No. D12967 downloaded from Genbank VRL May 28, 1999.
Takeuchi, K. et al. Accession Nos. D00574, D90080, M57585 downloaded from Genbank VRL Feb. 2, 1999.
Hall, W. et al. Accession No. L19383 downloaded from Genbank VRL Aug. 11, 1994.
Ogata, N. et al. Accession No. M62381 downloaded from Genbank VRL Jun. 10, 1996.
Odeberg, J. et al. Accession No. U24616 downloaded from Genbank VRL Feb. 23, 1996.
Odeberg, J. et al. Accession No. U24607 downloaded from Genbank VRL Feb. 23, 1996.
Kato, N. Accession No. X60573 downloaded from Genbank VRL Apr. 5, 1992.
Kato, N. et al. Accession No. D43650 downloaded from Genbank VRL Nov. 10, 1997.
Hohne, M. et al. Accession No. S73387 downloaded from Genbank VRL Aug. 22, 2000.
Wang, Y. et al. Accession No. D10934 downloaded from Genbank VRL Feb. 3, 1999.
Okamoto, H. et al. Accession No. D31972 downloaded from Genbank VRL Feb. 7, 1999.
Greene, W. et al. Accession No. U14231 downladed from Genbank VRL Jan. 27, 1995.
Odeberg, J. et al. Accession No. U24602 downloaded from Genbank VRL Feb. 23, 1996.
Hall, W. et al. Accession No. L19380 downloaded from Genbank VRL Aug. 11, 1994.
Liu, K. et al. Accession No. M74888 downloaded from Genbank VRL Aug. 2, 1993.
Han, J. et al. Accession No. L12354 downloaded from Genbank VRL Jul. 27, 1994.
Scarselli, E. et al. Accession No. X79672 downloaded from Gebank VRL Jun. 28. 1995.
Kato, N. et al. Accession No. D12952 downloaded from Genbank VR
Cortese Riccardo
Lahm Armin
Nicosia Alfredo
Tramontano Anna
Heber Sheldon O.
Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.A.
Tribble Jack L.
Wessendorf T. D.
LandOfFree
Mimotopes of hypervariable region 1 of the E2 glycoprotein... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mimotopes of hypervariable region 1 of the E2 glycoprotein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mimotopes of hypervariable region 1 of the E2 glycoprotein... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3578489